Cardiovascular Disease Risk Stratification Using Hybrid Deep Learning Paradigm: First of Its Kind on Canadian Trial Data.
Mrinalini BhagawatiSudip PaulLaura MantellaAmer M JohriSiddharth GuptaJohn R LairdInder M SinghNarendra N KhannaMustafa Al-MainiEsma R IsenovicEkta TiwariRajesh SinghAndrew NicolaidesLuca SabaVinod AnandJasjit S SuriPublished in: Diagnostics (Basel, Switzerland) (2024)
was scientifically validated, and the model was tested for reliability and stability and is further adaptable clinically.
Keyphrases
- deep learning
- cardiovascular disease
- phase iii
- study protocol
- electronic health record
- clinical trial
- artificial intelligence
- phase ii
- big data
- type diabetes
- convolutional neural network
- machine learning
- randomized controlled trial
- cardiovascular events
- cardiovascular risk factors
- open label
- coronary artery disease
- metabolic syndrome
- double blind
- placebo controlled